Lipid & Lp(a) therapies · Live ClinicalTrials.gov data

Olezarsen (Tryngolza) clinical trial pipeline

ClinicalTrials.gov lists 9 phase 2–4 trials for olezarsen (Tryngolza), 1 of them actively recruiting. The next phase 3 primary completion among them is expected Mar 2027. Refreshed daily. Add up to four competitors to compare pipelines side by side.

9

Phase 2–4 trials

8

Phase 3 trials

1

Actively recruiting

Mar 2027

Next phase 3 primary completion

3,742

Participants across trials

Ionis Pharmaceuticals, Inc.

Lead sponsor by trial count

olezarsen (9)4 active20202032
olezarsen
Key
Actual date
Anticipated
Forecast to primary completion
RecruitingActive, not recruitingCompleted
'20
'21
'22
'23
'24
'25
'26
'27
'28
'29
'30
'31
'32
olezarsen
BALANCEP3
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe HypertriglyceridemiaP3
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Participants With Familial Chylomicronemia Syndrome (FCS)P3
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRX) Administered to Adults With Familial Chylomicronemia Syndrome (FCS) Previously Treated With VolanesorsenP3
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe HypertriglyceridemiaP2
A Study of Olezarsen Administered Subcutaneously to Participants With Severe HypertriglyceridemiaP3
A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe HypertriglyceridemiaP3
CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)P3
A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric ParticipantsP3

Upcoming readouts

4 ahead · olezarsen

Select a trial to load its full ClinicalTrials.gov record.

Key olezarsen trials

Top 9 of the 9 registered phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.

Track olezarsen with ComplyRx

Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.

Track olezarsen

FAQ

How many clinical trials are running for olezarsen?
ClinicalTrials.gov currently lists 9 phase 2–4 olezarsen trials: 1 phase 2, 8 phase 3, and 0 phase 4. 1 are actively recruiting.
Are there clinical trials for Tryngolza?
Tryngolza is the brand name for olezarsen, so olezarsen trials on ClinicalTrials.gov cover it. ClinicalTrials.gov currently lists 9 phase 2–4 olezarsen trials: 1 phase 2, 8 phase 3, and 0 phase 4. 1 are actively recruiting.
Where does this data come from?
All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
Can I compare olezarsen against other drugs?
Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist

Be the first to access ComplyRx

We'll let you know as soon as your spot opens to use ComplyRx.

By joining, you agree to our Privacy Policy.